Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News > EU evaluates the safety of Panax notoginseng and Astragalus extract

EU evaluates the safety of Panax notoginseng and Astragalus extract

ECHEMI 2020-05-19

Recently, at the request of the European Commission, the European Food Safety Authority (EFSA) Nutrition, New Food and Food Allergen Group (NDA) issued an opinion on the safety of AstraGin as a new food.
 
It is understood that AstraGi is a plant extract extracted from Panax notoginseng and Astragalus membranaceus. The applicant recommends this new food as a food supplement for ordinary adults (excluding pregnant women) with a maximum daily dose of 350 mg.

Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.

Looking for chemical products? Let suppliers reach out to you!

Comment
Comment
  • Life Sciences Industry Overview

    The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.
    Published in: June.2026

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.